Brilinta 90mg Tablet is a prescription medicine containing Ticagrelor 90mg, a reversible P2Y12 platelet inhibitor. It works by preventing platelets from sticking together, reducing the formation of harmful blood clots inside blood vessels.
It is commonly prescribed for patients with acute coronary syndrome (ACS), myocardial infarction (heart attack), unstable angina, or those who have undergone coronary angioplasty with stent implantation. Brilinta is often used in combination with low-dose aspirin as advised by the treating physician. Regular use helps lower the risk of recurrent heart attack, stroke, and other serious cardiovascular events. Because it increases the risk of bleeding, it should only be taken under medical supervision.
⭐ Key Features
- Contains Ticagrelor 90mg
- Helps prevent blood clot formation
- Reduces the risk of heart attack and stroke
- Commonly prescribed after angioplasty and stent placement
- Often used with low-dose aspirin as directed by a physician
- Supports long-term cardiovascular protection
- Manufactured by AstraZeneca Pharma India Ltd.
